cGxP.wire https://validator.w3.org/feed/docs/rss2.html City of Hope Launches Phase 2 Lung Cancer Biomarker Trial Pheast Therapeutics Publishes New PHST001 Oncology Research Rapid Medical Receives FDA Clearance for DRIVEWIRE 35 JCR Pharmaceuticals Wins UAE Approval for IZCARGO Estrigenix Therapeutics Secures Seed Funding to Advance ERβ Platform Ipsen Completes Memo Therapeutics Acquisition Gilead Sciences Presents New HIV Prevention and Treatment Data at AIDS 2026 Atossa Unveils (Z)-Endoxifen Data for Rare Endocrine Disease Devonian Begins Pediatric Phase II/III Thykamine Trial Seegene USA Wins FDA EUA for Multiplex PCR Assay Belay Diagnostics Reports Strong Clinical Utility for Summit 2.0 Helus Pharma Completes Enrollment in Phase 3 HLP003 Trial Synergy Spine Accelerates Cervical Disc Adoption Across the U.S. Orasis Expands QLOSI Access as Refills Reach 49% BillionToOne Strengthens Northstar with New Oncology CMO Akagera Medicines Reports Positive Phase 1 AKG-100 Results Vesalio’s NATURE Trial Selected for ESC 2026 Late-Breaking Session Verismo Therapeutics Unveils New SynKIR-310 AACR Data Nektar Launches Phase 3 ZENITH AD Program for REZPEG Celldex Reports Phase 2 Barzolvolimab Results in Prurigo Nodularis Phanes Advances Spevatamig with Phase 2 PDAC Enrollment Complete Samsung Bioepis and Harrow Strengthen SB11 Clinical Evidence Nurix and Roche Complete Strategic Oncology Collaboration Telix Publishes ProstACT SELECT Study on TLX591-Tx Rein Therapeutics Expands Phase 2 RENEW Trial Across Five Countries Plus Therapeutics Secures Medical Mutual Coverage Agreement Akari and Whitehawk Launch ADC Research Partnership Enterome Reports Positive Phase 2 EO2463 Results Kyowa Kirin Wins EC Approval for Crysvita in Infants Haier Biomedical Unveils Digital Blood Management Platform Tempus to Acquire Personalis in $1.5B Precision Oncology Deal Bluejay Completes Patient Enrollment in SYMON-II Trial AdaptHealth Signs Definitive Sale Agreement with Cardinal Health Acadia Secures FDA Fast Track for Alzheimer’s Psychosis Drug Aptar Beauty Expands Packaging Innovation with NeoDropper Stereotaxis Launches Hungary’s First Robotic Cardiology Program Innate Pharma Reaches Phase 1 Enrollment Milestone for IPH4502 Fuse Oncology Unveils FuseRx to Transform Radiation Care Alliance for Building Better Medicine Secures $15.97M EDA Grant OMEICOS Advances OMT-28 to Phase 3 After FDA Meeting King Faisal Performs First Single-Incision Robotic Liver Transplant BIOTRONIK Neuro Launches AI-Powered Embrace One Platform Spectrum Dynamics Launches VERITON-CT 400 Enhancement Argo Biopharma Doses First Patient in BW-41012 Trial Gilead Sciences and Merck & Co. Deliver Positive ISLEND Phase 3 Results AbelZeta Earns EMA PRIME for C-CAR168 Lupus Therapy Valion Bio, Sheba Advance Entolimod Cancer Trial Lupin Spins Out Oncology Pipeline to Kaveri Therapeutics Organon, Samsung Bioepis Strengthen Australia Biosimilar Portfolio Seek Labs Validates ANINA Molecular Diagnostic Platform